Trinity Biotech PLC (TRIB)
1.80
-0.08
(-4.26%)
USD |
NASDAQ |
Apr 19, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Free Cash Flow (Quarterly): -5.284M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -5.284M |
| June 30, 2023 | -4.981M |
| March 31, 2023 | -3.347M |
| December 31, 2022 | 0.694M |
| September 30, 2022 | -0.648M |
| June 30, 2022 | -3.736M |
| March 31, 2022 | -3.208M |
| December 31, 2021 | 1.855M |
| September 30, 2021 | -0.262M |
| June 30, 2021 | -0.232M |
| March 31, 2021 | 3.186M |
| December 31, 2020 | 12.57M |
| September 30, 2020 | 4.34M |
| June 30, 2020 | 0.80M |
| March 31, 2020 | -4.152M |
| December 31, 2019 | -3.247M |
| September 30, 2019 | -1.415M |
| June 30, 2019 | 1.868M |
| March 31, 2019 | -3.642M |
| December 31, 2018 | -3.166M |
| September 30, 2018 | -9.313M |
| June 30, 2018 | 5.595M |
| March 31, 2018 | -3.278M |
| December 31, 2017 | -3.00M |
| September 30, 2017 | 0.344M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.248M |
| March 31, 2017 | -4.522M |
| December 31, 2016 | -2.771M |
| September 30, 2016 | -0.169M |
| June 30, 2016 | -4.91M |
| March 31, 2016 | -3.797M |
| December 31, 2015 | -4.254M |
| September 30, 2015 | -0.713M |
| June 30, 2015 | -6.218M |
| March 31, 2015 | -3.357M |
| December 31, 2014 | -3.359M |
| September 30, 2014 | -1.174M |
| June 30, 2014 | -2.905M |
| March 31, 2014 | -4.259M |
| December 31, 2013 | -8.176M |
| September 30, 2013 | -1.233M |
| June 30, 2013 | -2.558M |
| March 31, 2013 | -1.852M |
| December 31, 2012 | -0.732M |
| September 30, 2012 | 1.919M |
| June 30, 2012 | 2.096M |
| March 31, 2012 | 1.382M |
| December 31, 2011 | 1.29M |
| September 30, 2011 | 3.042M |
| June 30, 2011 | 3.003M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.284M
Minimum
Sep 2023
12.57M
Maximum
Dec 2020
-0.2889M
Average
-0.455M
Median
Free Cash Flow (Quarterly) Benchmarks
| Amarin Corp PLC | -1.154M |
| Avadel Pharmaceuticals PLC | -28.03M |
| DBV Technologies SA | -14.04M |
| Adaptimmune Therapeutics PLC | -15.50M |
| Akari Therapeutics PLC | -- |